Management of the asymptomatic primary in the palliative treatment of metastatic colorectal cancer.
OBJECTIVE: The management of the asymptomatic primary in stage IV colorectal cancer presents a dilemma. There is an increased morbidity and mortality from surgical resection. Nonresectional management of the primary is associated with the risks of obstruction, perforation or haemorrhage. Our practi...
Principais autores: | Clements, D, Dhruva Rao, P, Ramanathan, D, Adams, R, Maughan, T, Davies, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2009
|
Registros relacionados
-
Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
por: Adams, R, et al.
Publicado em: (2008) -
Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial.
por: Maughan, T, et al.
Publicado em: (2002) -
Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy
por: Schwörer Harald, et al.
Publicado em: (2009-07-01) -
Asymptomatic Primary Tumor Resection in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Yefei Shu, et al.
Publicado em: (2022-03-01) -
Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients
por: Sophie A. Kurk, et al.
Publicado em: (2018-10-01)